Regeneron Pharmaceuticals
REGN
#231
Rank
S$104.51 B
Marketcap
$951.08
Share price
-0.90%
Change (1 day)
-14.84%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $50.37

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $50.63. In 2022 the company made an earnings per share (EPS) of $54.91 a decrease over its 2021 EPS that were of $103.60.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$50.37-8.26%
2022$54.91-47%
2021$103.60133.36%
2020$44.3969.13%
2019$26.25-14.44%
2018$30.68100.71%
2017$15.2931.78%
2016$11.6038.96%
2015$8.3572.55%
2014$4.84-17.55%
2013$5.87-44.98%
2012$10.66-422.54%
2011-$3.3192.13%
2010-$1.7249.41%
2009-$1.15-15.84%
2008-$1.37-36.88%
2007-$2.17-9.6%
2006-$2.404.12%
2005-$2.30-323.68%
2004$1.03-135.51%
2003-$2.90-24.38%
2002-$3.8356.35%
2001-$2.45187.3%
2000-$0.85-16%
1999-$1.02177.78%
1998-$0.37-35.71%
1997-$0.57-68.42%
1996-$1.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$19.17-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.57-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.02-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.09-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.07-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$4.31-91.49%๐Ÿ‡ซ๐Ÿ‡ท France